The Fatal Flaws in the “Abortion Pill” Decision
By second-guessing FDA safety determinations, the Fifth Circuit challenges the Supreme Court to restore agency deference.
Peter Grossi
Peter Grossi teaches drug product liability litigation at the University of Pennsylvania Carey Law School.